Oral prednisolone versus non-steroidal anti-inflammatory drugs in the treatment of acute gout: a meta-analysis of randomized controlled trials

[1]  M. Ruospo,et al.  Corticosteroid or Nonsteroidal Antiinflammatory Drugs for the Treatment of Acute Gout: A Systematic Review of Randomized Controlled Trials , 2018, The Journal of Rheumatology.

[2]  Youde Yan,et al.  Benefit-risk of corticosteroids in acute gout patients: An updated meta-analysis and economic evaluation , 2017, Steroids.

[3]  C. Nunes,et al.  Nonsteroidal Anti‐Inflammatory Therapy: A Journey Toward Safety , 2017, Medicinal research reviews.

[4]  Chengping Wen,et al.  Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta‐analysis , 2017, Life sciences.

[5]  M. Doherty,et al.  Gout - a guide for the general and acute physicians. , 2017, Clinical medicine.

[6]  P. Shekelle,et al.  Management of Gout: A Systematic Review in Support of an American College of Physicians Clinical Practice Guideline , 2017 .

[7]  A. Qaseem,et al.  Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians. , 2017, Annals of internal medicine.

[8]  Kathryn Majors-Foley.  Oral Prednisolone in the Treatment of Acute Gout: A Pragmatic, Multicenter, Double-Blind, Randomized Trial , 2016 .

[9]  Meiping Guan,et al.  Comparison of Prednisolone, Etoricoxib, and Indomethacin in Treatment of Acute Gouty Arthritis: An Open-Label, Randomized, Controlled Trial , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[10]  T. Rainer,et al.  Oral Prednisolone in the Treatment of Acute Gout: A Pragmatic, Multicenter, Double-Blind, Randomized Trial. , 2016, Annals of internal medicine.

[11]  Zhong Chen,et al.  The efficacy and safety of rufinamide in drug-resistant epilepsy: A meta-analysis of double-blind, randomized, placebo controlled trials , 2016, Epilepsy Research.

[12]  R. Nixon,et al.  Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis , 2015, Arthritis Research & Therapy.

[13]  C. Bombardier,et al.  The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors. , 2014, The Journal of rheumatology. Supplement.

[14]  F. Becce,et al.  2016 updated EULAR evidence-based recommendations for the management of gout , 2014, Annals of the rheumatic diseases.

[15]  P. McGettigan,et al.  Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies , 2011, PLoS medicine.

[16]  T. Rainer,et al.  Oral prednisolone is more cost-effective than oral indomethacin for treating patients with acute gout-like arthritis , 2009, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[17]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[18]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[19]  C. Weel,et al.  Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial , 2008, The Lancet.

[20]  P. Lucassen,et al.  Systemic corticosteroids for acute gout. , 2008, The Cochrane database of systematic reviews.

[21]  P. Cameron,et al.  Comparison of Oral Prednisolone/Paracetamol and Oral Indomethacin/Paracetamol Combination Therapy in the Treatment of Acute Goutlike Arthritis: A Double-Blind, Randomized, Controlled Trial , 2007, Annals of Emergency Medicine.

[22]  Joseph Beyene,et al.  Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data , 2007, BMC medical research methodology.

[23]  Frieder Keller,et al.  Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids , 2005, Clinical Pharmacokinetics.

[24]  M. Oremus,et al.  Interrater Reliability of the Modified Jadad Quality Scale for Systematic Reviews of Alzheimer’s Disease Drug Trials , 2001, Dementia and Geriatric Cognitive Disorders.

[25]  M. Janssen,et al.  Systemic corticosteroids for acute gout (Review) , 2008 .